CD47 and central nervous system cancer: A recent report revealed that administration of RRx‐001, an anti‐CD47‐SIRPα small molecule with vascular normalizing properties, prior to temozolomide or irinotecan results in increased drug uptake in orthotropic glioma tumors.91